You searched for "patient"
Changes in refractive error in patients with accommodative esotropia after being weaned from hyperopic correction
This is a retrospective review of medical records of 47 patients with refractive ocular accommodative esotropia who achieved emmetropisation and orthotropia without hyperopic glasses correction and were followed up for at least three years. The objective of the study is...
Incomplete teprotumumab treatment for thyroid eye disease
This is a multi-centre retrospective analysis of clinical outcomes in patients who were on teprotumumab for thyroid eye disease but had the usual regime of eight infusions, three weeks apart, interrupted due to COVID-19. Manufacturing was suspended between Dec 2020...
The use of adalimumab for relapse in patients with Vogt-Koyanagi-Harada disease
In this retrospective, multi-centre, cohort study, the efficacy and safety of Adalimumab (ADA) treatment for the exacerbation or recurrence of Vogt-Koyanagi-Harada (VKH) patients was assessed by investigating the medical records of patients who had received ADA treatment for more than...My top five: Innovative approaches to dry AMD
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...My Top Five: Innovative approaches to dry AMD
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...Make eye drops part of your Ramadan routine: wake, drops, eat, pray, done!
During the holy month of Ramadan, Muslims fast during daylight hours, abstaining from food and drink between dawn and sunset each day. Ramadan 2020 starts on 23 April and ends around 23 May, depending on the first appearance of the...Development of retinoblastoma care in Indonesia and the role of multidisciplinary team meetings
In the second article of a two-part series (See Part 1 here), the authors focus on the diagnosis and management of retinoblastoma in Indonesia. COVID-19 doesn’t get thanked for many things, but on 19 December 2020 as the world grew...Cataract surgery training in the independent sector
I am now most of the way through my ST3 year working in Plymouth, within the Peninsula Deanery. Before the start of the year, I was approached by one of my consultants who asked if I would like to carry...DR-NET National DR Workshop in Tanzania: Policy, training and technology
Diabetic retinopathy (DR) is a leading cause of moderate to severe visual impairment (VI) and blindness worldwide, posing a significant public health challenge. As the prevalence of diabetes continues to rise globally, particularly in low- and middle-income countries (LMICs), the...
Intravitreal dexamethasone implant for recurrent CMO secondary to IGS
In this prospective study the authors present the data obtained on the efficacy and safety of the dexamethasone implant (0.7 mg) in the treatment of recurrent cystoid macular oedema (PCME) due to Irvine–Gass syndrome in patients with uncomplicated pseudophakia (off-label...
